general_characteristics,tumor_and_lesion_localization,previous_cancer_treatments,prior_primary_tumors,molecular_results,laboratory_measurements,other_conditions,cardiac_function,infections,current_medications,washout_period,reproduction,complications,intolerances_and_toxicities,vital_function_and_bodyweight_measurements,blood_transfusions,surgery
IS_AT_LEAST_X_YEARS_OLD,HAS_SOLID_PRIMARY_TUMOR,CURRENTLY_GETS_CHEMORADIOTHERAPY_OF_TYPE_X_CHEMOTHERAPY_AND_AT_LEAST_Y_CYCLES,HAS_ACTIVE_SECOND_MALIGNANCY,DRIVER_EVENT_IN_ANY_GENES_X_WITH_APPROVED_THERAPY_AVAILABLE,HAS_LEUKOCYTES_ABS_OF_AT_LEAST_X,HAS_HISTORY_OF_SPECIFIC_CONDITION_WITH_ICD_TITLE_X,HAS_POTENTIAL_SIGNIFICANT_HEART_DISEASE,HAS_ACTIVE_INFECTION,CURRENTLY_GETS_NAME_X_MEDICATION,HAS_RECEIVED_DRUGS_X_CANCER_THERAPY_WITHIN_Y_WEEKS,IS_BREASTFEEDING,HAS_ANY_COMPLICATION,HAS_INTOLERANCE_TO_NAME_X,HAS_SBP_MMHG_OF_AT_LEAST_X,REQUIRES_REGULAR_HEMATOPOIETIC_SUPPORT,HAS_HAD_RECENT_SURGERY
IS_MALE,HAS_SOLID_PRIMARY_TUMOR_INCLUDING_LYMPHOMA,IS_NOT_ELIGIBLE_FOR_TREATMENT_WITH_CURATIVE_INTENT,HAS_HISTORY_OF_SECOND_MALIGNANCY,HAS_MOLECULAR_EVENT_WITH_SOC_TARGETED_THERAPY_AVAILABLE_IN_NSCLC,HAS_LEUKOCYTES_ABS_LLN_OF_AT_LEAST_X,HAS_HISTORY_OF_SPECIFIC_CONDITION_WITH_ICD_TITLE_X_WITHIN_Y_MONTHS,HAS_ECG_ABERRATION,HAS_KNOWN_EBV_INFECTION,CURRENTLY_GETS_CATEGORY_X_MEDICATION,HAS_RECEIVED_DRUGS_X_CANCER_THERAPY_WITHIN_Y_WEEKS_Z_HALF_LIVES,IS_PREGNANT,HAS_COMPLICATION_WITH_ANY_ICD_TITLE_X,HAS_INTOLERANCE_WITH_ICD_TITLE_X,HAS_SBP_MMHG_OF_AT_MOST_X,HAS_HAD_ERYTHROCYTE_TRANSFUSION_WITHIN_LAST_X_WEEKS,HAS_HAD_SURGERY_WITHIN_LAST_X_WEEKS
IS_FEMALE,HAS_PRIMARY_TUMOR_LOCATION_BELONGING_TO_ANY_DOID_TERM_X,IS_ELIGIBLE_FOR_ON_LABEL_TREATMENT_X,HAS_HISTORY_OF_SECOND_MALIGNANCY_IGNORING_DOID_TERMS_X,HAS_MOLECULAR_EVENT_WITH_SOC_TARGETED_THERAPY_AVAILABLE_IN_NSCLC_EXCLUDING_ANY_GENE_X,HAS_LYMPHOCYTES_ABS_OF_AT_LEAST_X,HAS_HISTORY_OF_SPECIFIC_CONDITION_X_BY_NAME,HAS_LVEF_OF_AT_LEAST_X,HAS_KNOWN_HEPATITIS_A_INFECTION,HAS_RECEIVED_CATEGORY_X_MEDICATION_ WITHIN_Y_WEEKS,HAS_RECEIVED_CATEGORIES_X_CANCER_THERAPY_WITHIN_Y_WEEKS,USES_ADEQUATE_ANTICONCEPTION,HAS_POTENTIAL_UNCONTROLLED_TUMOR_RELATED_PAIN,HAS_INTOLERANCE_TO_PLATINUM_COMPOUNDS,HAS_DBP_MMHG_OF_AT_LEAST_X,HAS_HAD_THROMBOCYTE_TRANSFUSION_WITHIN_LAST_X_WEEKS,HAS_HAD_SURGERY_WITHIN_LAST_X_MONTHS
HAS_WHO_STATUS_OF_AT_MOST_X,HAS_PRIMARY_TUMOR_LOCATION_BELONGING_TO_ANY_DOID_TERM_X _DISTAL_SUB_LOCATION,IS_ELIGIBLE_FOR_RADIOTHERAPY,HAS_HISTORY_OF_SECOND_MALIGNANCY_BELONGING_TO_DOID_TERM_X,ACTIVATION_OR_AMPLIFICATION_OF_GENE_X,HAS_LYMPHOCYTES_CELLS_PER_MM3_OF_AT_LEAST_X,HAS_HISTORY_OF_SPECIFIC_CONDITION_X_BY_NAME_WITHIN_Y_MONTHS,HAS_QTC_OF_AT_MOST_X,HAS_KNOWN_HEPATITIS_B_INFECTION,CURRENTLY_GETS_POTENTIALLY_QT_PROLONGATING_MEDICATION,HAS_RECEIVED_CATEGORIES_X_CANCER_THERAPY_WITHIN_Y_WEEKS_Z_HALF_LIVES,ADHERES_TO_SPERM_OR_EGG_DONATION_PRESCRIPTIONS,HAS_LEPTOMENINGEAL_DISEASE,HAS_INTOLERANCE_TO_TAXANE,HAS_DBP_MMHG_OF_AT_MOST_X,,HAS_PLANNED_SURGERY
HAS_WHO_STATUS_OF_AT_EXACTLY_X,HAS_CANCER_OF_UNKNOWN_PRIMARY_AND_TYPE_X,IS_ELIGIBLE_FOR_RADIOTHERAPY_TO_BODY_LOCATION_X,HAS_HISTORY_OF_SECOND_MALIGNANCY_WITHIN_X_YEARS,ACTIVATING_MUTATION_IN_ANY_GENES_X,HAS_NEUTROPHILS_ABS_OF_AT_LEAST_X,HAS_HISTORY_OF_AUTOIMMUNE_DISEASE,HAS_QTCF_OF_AT_MOST_X,HAS_KNOWN_HEPATITIS_C_INFECTION,CURRENTLY_GETS_MEDICATION_INDUCING_ANY_CYP,HAS_RECEIVED_TRIAL_MEDICATION_WITHIN_X_WEEKS,,,HAS_INTOLERANCE_RELATED_TO_STUDY_MEDICATION,HAS_PULSE_OXIMETRY_OF_AT_LEAST_X,,HAS_HAD_CYTOREDUCTIVE_SURGERY
HAS_KARNOFSKY_SCORE_OF_AT_LEAST_X,HAS_CANCER_WITH_NEUROENDOCRINE_COMPONENT,IS_ELIGIBLE_FOR_PALLIATIVE_RADIOTHERAPY,HAS_HISTORY_OF_SECOND_MALIGNANCY_WITHIN_X_YEARS_IGNORING_DOID_TERMS_Y,ACTIVATING_MUTATION_IN_GENE_X_EXCLUDING_CODONS_Y,HAS_THROMBOCYTES_ABS_OF_AT_LEAST_X,HAS_HISTORY_OF_CARDIAC_DISEASE,HAS_QTCF_OF_AT_MOST_X_WITH_GENDER_Y,HAS_KNOWN_HIV_INFECTION,CURRENTLY_GETS_MEDICATION_INHIBITING_CYP_X,HAS_RECEIVED_TRIAL_MEDICATION_WITHIN_X_WEEKS_Y_HALF_LIVES,,,HAS_INTOLERANCE_FOR_PD_1_OR_PD_L1_INHIBITORS,HAS_RESTING_HEART_RATE_BETWEEN_X_AND_Y,,HAS_HAD_ONCOLOGICAL_SURGERY_TO_ANY_BODY_LOCATION_X
HAS_LANSKY_SCORE_OF_AT_LEAST_X,HAS_CANCER_WITH_SMALL_CELL_COMPONENT,IS_ELIGIBLE_FOR_LOCO_REGIONAL_THERAPY,,AMPLIFICATION_OF_GENE_X,HAS_HEMOGLOBIN_G_PER_DL_OF_AT_LEAST_X,HAS_HISTORY_OF_CARDIOVASCULAR_DISEASE,HAS_QTCF_OF_AT_LEAST_X,HAS_KNOWN_HSV_INFECTION,CURRENTLY_GETS_MEDICATION_INDUCING_CYP_X,HAS_RECEIVED_RADIOTHERAPY_WITHIN_X_WEEKS,,,HAS_HISTORY_OF_ANAPHYLAXIS,HAS_BODY_WEIGHT_OF_AT_LEAST_X,,
CAN_GIVE_ADEQUATE_INFORMED_CONSENT,HAS_KNOWN_SCLC_TRANSFORMATION,IS_ELIGIBLE_FOR_TREATMENT_LINES_X,,AMPLIFICATION_OF_GENE_X_OF_AT_LEAST_Y_COPIES,HAS_HEMOGLOBIN_MMOL_PER_L_OF_AT_LEAST_X,HAS_HISTORY_OF_CONGESTIVE_HEART_FAILURE_WITH_AT_LEAST_NYHA_CLASS_X,HAS_QTCF_OF_AT_LEAST_X_WITH_GENDER_Y,HAS_KNOWN_CYTOMEGALOVIRUS_INFECTION,HAS_RECEIVED_MEDICATION_INDUCING_CYP_X_WITHIN_Y_WEEKS,HAS_HAD_RADIOTHERAPY_TO_BODY_LOCATION_X_WITHIN_Y_WEEKS,,,HAS_EXPERIENCED_IMMUNOTHERAPY_RELATED_ADVERSE_EVENTS,HAS_BODY_WEIGHT_OF_AT_MOST_X,,
HAS_LIFE_EXPECTANCY_OF_AT_LEAST_X_WEEKS,HAS_NON_SQUAMOUS_NSCLC,IS_ELIGIBLE_FOR_LOCAL_LIVER_TREATMENT,,COPY_NUMBER_OF_GENE_X_OF_AT_LEAST_Y,HAS_POTENTIAL_LEUKOCYTOSIS,HAS_HISTORY_OF_CENTRAL_NERVOUS_SYSTEM_DISEASE,HAS_JTC_OF_AT_LEAST_X,HAS_KNOWN_TUBERCULOSIS_INFECTION,CURRENTLY_GETS_MEDICATION_INHIBITING_OR_INDUCING_ANY_CYP,HAS_RECEIVED_ANY_ANTI_CANCER_THERAPY_WITHIN_X_WEEKS,,,HAS_TOXICITY_CTCAE_OF_AT_LEAST_GRADE_X,HAS_BMI_OF_AT_MOST_X,,
HAS_LIFE_EXPECTANCY_OF_AT_LEAST_X_MONTHS,HAS_BREAST_CANCER_RECEPTOR_X_POSITIVE,IS_ELIGIBLE_FOR_INTENSIVE_TREATMENT,,MUTATION_IN_GENE_X_OF_ANY_PROTEIN_IMPACTS_Y,HAS_INR_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_EYE_DISEASE,HAS_LONG_QT_SYNDROME,MEETS_COVID_19_INFECTION_REQUIREMENTS,CURRENTLY_GETS_MEDICATION_INHIBITING_OR_INDUCING_CYP_X,HAS_RECEIVED_ANY_ANTI_CANCER_THERAPY_EXCL_CATEGORIES_X_WITHIN_Y_WEEKS,,,HAS_TOXICITY_CTCAE_OF_AT_LEAST_GRADE_X_WITH_ANY_ICD_TITLE_Y,,,
WILL_PARTICIPATE_IN_TRIAL_IN_COUNTRY_X,HAS_OVARIAN_CANCER_WITH_MUCINOUS_COMPONENT,IS_ELIGIBLE_FOR_FIRST_LINE_PALLIATIVE_CHEMOTHERAPY,,MUTATION_IN_GENE_X_IN_ANY_CODONS_Y,HAS_PT_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_GASTROINTESTINAL_DISEASE,HAS_NORMAL_CARDIAC_FUNCTION_BY_MUGA_OR_TTE,HAS_RECEIVED_LIVE_VACCINE_WITHIN_X_MONTHS,CURRENTLY_GETS_MEDICATION_SUBSTRATE_OF_CYP_X,HAS_RECEIVED_ANY_ANTI_CANCER_THERAPY_WITHIN_X_WEEKS_Y_HALF_LIVES,,,HAS_TOXICITY_ASTCT_OF_AT_LEAST_GRADE_X_WITH_ANY_ICD_TITLE_Y,,,
IS_LEGALLY_INSTITUTIONALIZED,HAS_OVARIAN_BORDERLINE_TUMOR,IS_ELIGIBLE_FOR_LOCAL_TREATMENT_OF_METASTASES,,MUTATION_IN_GENE_X_IN_EXON_Y,HAS_PT_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,HAS_HISTORY_OF_IMMUNE_SYSTEM_DISEASE,HAS_FAMILY_HISTORY_OF_IDIOPATHIC_SUDDEN_DEATH,HAS_RECEIVED_NON_LIVE_VACCINE_WITHIN_X_WEEKS,CURRENTLY_GETS_MEDICATION_INHIBITING_TRANSPORTER_X,HAS_RECEIVED_ANY_ANTI_CANCER_THERAPY_EXCL_CATEGORIES_X_WITHIN_Y_WEEKS_Z_HALF_LIVES,,,HAS_TOXICITY_CTCAE_OF_AT_LEAST_GRADE_X_IGNORING_ICD_TITLES_Y,,,
IS_INVOLVED_IN_STUDY_PROCEDURES,HAS_STOMACH_UNDIFFERENTIATED_TUMOR,IS_ELIGIBLE_FOR_SURGERY_TYPE_X,,MUTATION_IN_GENE_X_IN_EXON_Y_TO_EXON_Z,HAS_APTT_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_INTERSTITIAL_LUNG_DISEASE_INCLUDING_PNEUMONITIS,HAS_FAMILY_HISTORY_OF_LONG_QT_SYNDROME,ADHERENCE_TO_PROTOCOL_REGARDING_ ATTENUATED_VACCINE_USE,CURRENTLY_GETS_MEDICATION_SUBSTRATE_OF_TRANSPORTER_X,,,,,,,
USES_TOBACCO_PRODUCTS,HAS_SECONDARY_GLIOBLASTOMA,IS_ELIGIBLE_FOR_TREATMENT_OF_CATEGORY_X_AND_ANY_TYPE_Y,,MUTATION_IN_GENE_X_IN_EXON_Y_OF_TYPE_Z,HAS_APTT_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,HAS_POTENTIAL_RESPIRATORY_COMPROMISE,MEETS_REQUIREMENTS_DURING_CARDIAC_STRESS_TEST,,CURRENTLY_GETS_MEDICATION_SUBSTRATE_OR_INHIBITING_ANY_NON_EVALUABLE_TRANSPORTER_X,,,,,,,
ADHERES_TO_BLOOD_DONATION_PRESCRIPTIONS,HAS_CYTOLOGICAL_DOCUMENTATION_OF_TUMOR_TYPE,HAS_EXHAUSTED_SOC_TREATMENTS,,INACTIVATION_OF_GENE_X,HAS_PTT_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_LIVER_DISEASE,,,HAS_STABLE_ANTICOAGULANT_MEDICATION_DOSING,,,,,,,
,HAS_HISTOLOGICAL_DOCUMENTATION_OF_TUMOR_TYPE,HAS_HAD_AT_LEAST_X_APPROVED_TREATMENT_LINES,,UTR_3_LOSS_IN_GENE_X,HAS_ALBUMIN_G_PER_DL_OF_AT_LEAST_X,HAS_HISTORY_OF_LUNG_DISEASE,,,CURRENTLY_GETS_HERBAL_MEDICATION,,,,,,,
,HAS_PATHOLOGICAL_DOCUMENTATION_OF_TUMOR_TYPE,HAS_HAD_AT_LEAST_X_SYSTEMIC_TREATMENT_LINES,,FUSION_IN_GENE_X,HAS_ALBUMIN_LLN_OF_AT_LEAST_X,HAS_HISTORY_OF_MYOCARDIAL_INFARCT,,,,,,,,,,
,HAS_ANY_STAGE_X,HAS_HAD_AT_MOST_X_SYSTEMIC_TREATMENT_LINES,,WILDTYPE_OF_GENE_X,HAS_ASAT_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_MYOCARDIAL_INFARCT_WITHIN_X_MONTHS,,,,,,,,,,
,HAS_TNM_T_SCORE_X,HAS_HAD_ANY_CANCER_TREATMENT,,EXON_SKIPPING_GENE_X_EXON_Y,HAS_ALAT_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_PNEUMONITIS,,,,,,,,,,
,HAS_LOCALLY_ADVANCED_CANCER,HAS_HAD_ANY_CANCER_TREATMENT_WITHIN_X_MONTHS,,MSI_SIGNATURE,HAS_ASAT_AND_ALAT_ULN_OF_AT_MOST_X_OR_AT_MOST_Y_WHEN_LIVER_METASTASES_PRESENT,HAS_HISTORY_OF_STROKE,,,,,,,,,,
,HAS_METASTATIC_CANCER,HAS_HAD_ANY_SYSTEMIC_CANCER_TREATMENT_WITHIN_X_MONTHS,,HRD_SIGNATURE,HAS_ALP_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_STROKE_WITHIN_X_MONTHS,,,,,,,,,,
,HAS_UNRESECTABLE_CANCER,HAS_HAD_ANY_CANCER_TREATMENT_IGNORING_CATEGORY_X,,HRD_SIGNATURE_WITHOUT_MUTATION_OR_WITH_VUS_MUTATION_IN_GENES_X,HAS_ALP_ULN_OF_AT_LEAST_X,HAS_HISTORY_OF_THROMBOEMBOLIC_EVENT,,,,,,,,,,
,HAS_UNRESECTABLE_STAGE_III_CANCER,HAS_HAD_TREATMENT_NAME_X,,HRD_SIGNATURE_WITHOUT_MUTATION_IN_GENES_X,HAS_TOTAL_BILIRUBIN_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_THROMBOEMBOLIC_EVENT_WITHIN_X_MONTHS,,,,,,,,,,
,HAS_RECURRENT_CANCER,HAS_HAD_TREATMENT_NAME_X_WITHIN_Y_WEEKS,,TMB_OF_AT_LEAST_X,HAS_TOTAL_BILIRUBIN_ULN_OF_AT_MOST_X_OR_Y_IF_GILBERT_DISEASE,HAS_HISTORY_OF_ARTERIAL_THROMBOEMBOLIC_EVENT,,,,,,,,,,
,HAS_INCURABLE_CANCER,HAS_HAD_FIRST_LINE_SYSTEMIC_TREATMENT_NAME_X,,TML_OF_AT_LEAST_X,HAS_TOTAL_BILIRUBIN_ULN_OF_AT_MOST_X_OR_DIRECT_BILIRUBIN_ULN_OF_AT_MOST_Y_IF_GILBERT_DISEASE,HAS_HISTORY_OF_VENOUS_THROMBOEMBOLIC_EVENT,,,,,,,,,,
,HAS_ANY_LESION,HAS_HAD_FIRST_LINE_TREATMENT_NAME_X_WITHOUT_PROGRESSION_AND_AT_LEAST_Y_CYCLES,,TML_BETWEEN_X_AND_Y,HAS_TOTAL_BILIRUBIN_UMOL_PER_L_OF_AT_MOST_X,HAS_HISTORY_OF_VASCULAR_DISEASE,,,,,,,,,,
,HAS_AT_MOST_X_DISTANT_METASTASES,HAS_HAD_DRUG_X_COMBINED_WITH_CATEGORY_Y_TREATMENT_OF_TYPES_Z,,HAS_HLA_TYPE_X,HAS_TOTAL_BILIRUBIN_MG_PER_DL_OF_AT_MOST_X,HAS_HISTORY_OF_ULCER,,,,,,,,,,
,MEETS_SPECIFIC_CRITERIA_REGARDING_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_COMBINED_WITH_CATEGORY_Z_TREATMENT_OF_TYPES_A,,HAS_HLA_GROUP_X,HAS_DIRECT_BILIRUBIN_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_BLEEDING,,,,,,,,,,
,HAS_LIVER_METASTASES,HAS_HAD_TREATMENT_WITH_ANY_DRUG_X,,HAS_UGT1A1_HAPLOTYPE_X,HAS_DIRECT_BILIRUBIN_PERCENTAGE_OF_TOTAL_OF_AT_MOST_X,HAS_HISTORY_OF_WOUND,,,,,,,,,,
,HAS_LIVER_METASTASES_ONLY,HAS_HAD_TREATMENT_WITH_ANY_DRUG_X_AS_MOST_RECENT_LINE,,HAS_HOMOZYGOUS_DPYD_DEFICIENCY,HAS_INDIRECT_BILIRUBIN_ULN_OF_AT_MOST_X,HAS_HISTORY_OF_BONE_FRACTURE,,,,,,,,,,
,MEETS_SPECIFIC_CRITERIA_REGARDING_LIVER_METASTASES,HAS_HAD_COMBINED_TREATMENT_NAMES_X_AND_BETWEEN_Y_AND_Z_CYCLES,,HAS_HETEROZYGOUS_DPYD_DEFICIENCY,HAS_CREATININE_MG_PER_DL_OF_AT_MOST_X,HAS_SEVERE_CONCOMITANT_CONDITION,,,,,,,,,,
,HAS_KNOWN_CNS_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT,,HAS_KNOWN_HPV_STATUS,HAS_CREATININE_ULN_OF_AT_MOST_X,HAS_HAD_ORGAN_TRANSPLANT,,,,,,,,,,
,HAS_KNOWN_ACTIVE_CNS_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y,,OVEREXPRESSION_OF_ANY_GENE_X,HAS_EGFR_CKD_EPI_OF_AT_LEAST_X,HAS_HAD_ORGAN_TRANSPLANT_WITHIN_X_YEARS,,,,,,,,,,
,HAS_KNOWN_BRAIN_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_OF_ALL_TYPES_Y,,NON_EXPRESSION_OF_ANY_GENE_X,HAS_EGFR_MDRD_OF_AT_LEAST_X,HAS_GILBERT_DISEASE,,,,,,,,,,
,HAS_KNOWN_ACTIVE_BRAIN_METASTASES,HAS_HAD_FIRST_LINE_CATEGORY_X_OF_TYPES_Y_THERAPY,,SPECIFIC_MRNA_EXPRESSION_REQUIREMENTS_MET_FOR_GENES_X,HAS_CREATININE_CLEARANCE_CG_OF_AT_LEAST_X,HAS_HYPERTENSION,,,,,,,,,,
,MEETS_SPECIFIC_CRITERIA_REGARDING_BRAIN_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_WITHIN_Z_WEEKS,,LOSS_OF_PROTEIN_X_BY_IHC,HAS_CREATININE_CLEARANCE_BETWEEN_X_AND_Y,HAS_HYPOTENSION,,,,,,,,,,
,HAS_EXTRACRANIAL_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_IGNORING_TYPES_Y,,EXPRESSION_OF_PROTEIN_X_BY_IHC,HAS_MEASURED_CREATININE_CLEARANCE_OF_AT_LEAST_X,HAS_DIABETES,,,,,,,,,,
,HAS_BONE_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_IGNORING_TYPES_Y_WITHIN_Z_WEEKS,,EXPRESSION_OF_PROTEIN_X_BY_IHC_OF_EXACTLY_Y,HAS_BNP_ULN_OF_AT_MOST_X,HAS_INHERITED_PREDISPOSITION_TO_BLEEDING_OR_THROMBOSIS,,,,,,,,,,
,HAS_BONE_METASTASES_ONLY,HAS_HAD_CATEGORY_X_TREATMENT_IGNORING_DRUGS_Y,,EXPRESSION_OF_PROTEIN_X_BY_IHC_OF_AT_LEAST_Y,HAS_TROPONIN_I_OR_T_ULN_OF_AT_MOST_X,HAS_POTENTIAL_ABSORPTION_DIFFICULTIES,,,,,,,,,,
,HAS_LUNG_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_IGNORING_DRUGS_Z,,EXPRESSION_OF_PROTEIN_X_BY_IHC_OF_AT_MOST_Y,HAS_TRIGLYCERIDE_MMOL_PER_L_OF_AT_MOST_X,HAS_POTENTIAL_ORAL_MEDICATION_DIFFICULTIES,,,,,,,,,,
,HAS_LYMPH_NODE_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_AND_AT_LEAST_Y_LINES,,PROTEIN_X_IS_WILD_TYPE_BY_IHC,HAS_AMYLASE_ULN_OF_AT_MOST_X,HAS_POTENTIAL_CONTRAINDICATION_TO_CT,,,,,,,,,,
,HAS_VISCERAL_METASTASES,HAS_HAD_CATEGORY_X_TREATMENT_AND_AT_MOST_Y_LINES,,HER2_STATUS_IS_POSITIVE,HAS_LIPASE_ULN_OF_AT_MOST_X,HAS_POTENTIAL_CONTRAINDICATION_TO_MRI,,,,,,,,,,
,HAS_UNRESECTABLE_PERITONEAL_METASTASES,HAS_NOT_HAD_CATEGORY_X_TREATMENT_OR_AT_MOST_Y_LINES,,PD_L1_SCORE_OF_AT_LEAST_X,HAS_ABNORMAL_ELECTROLYTE_LEVELS,HAS_POTENTIAL_CONTRAINDICATION_TO_PET_MRI,,,,,,,,,,
,HAS_LESIONS_CLOSE_TO_OR_INVOLVING_AIRWAY,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_AND_AT_LEAST_Z_LINES,,PD_L1_SCORE_OF_AT_MOST_X,HAS_CALCIUM_MG_PER_DL_OF_AT_MOST_X,HAS_POTENTIAL_CONTRAINDICATION_FOR_PET_CT_SCAN,,,,,,,,,,
,HAS_LESION_COUNT_OF_AT_LEAST_X_IN_BODY_LOCATION_Y,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_AND_AT_MOST_Z_LINES,,PD_L1_SCORE_CPS_OF_AT_LEAST_X,HAS_CALCIUM_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,HAS_MRI_SCAN_DOCUMENTING_STABLE_DISEASE,,,,,,,,,,
,HAS_EXTENSIVE_SYSTEMIC_METASTASES_PREDOMINANTLY_DETERMINING_PROGNOSIS,HAS_NOT_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_OR_AT_MOST_Z_LINES,,PD_L1_SCORE_CPS_OF_AT_MOST_X,HAS_CORRECTED_CALCIUM_ULN_OF_AT_MOST_X,IS_IN_DIALYSIS,,,,,,,,,,
,HAS_BIOPSY_AMENABLE_LESION,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_WITH_STOP_REASON_OTHER_THAN_PD,,PD_L1_SCORE_TPS_OF_AT_LEAST_X,HAS_CORRECTED_CALCIUM_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,HAS_CHILD_PUGH_SCORE_X,,,,,,,,,,
,HAS_IRRADIATION_AMENABLE_LESION,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_FOR_AT_MOST_Z_WEEKS_WITH_STOP_REASON_OTHER_THAN_PD,,PD_L1_SCORE_TPS_OF_AT_MOST_X,HAS_IONIZED_CALCIUM_MMOL_PER_L_OF_AT_MOST_X,HAS_POTENTIAL_CONTRAINDICATION_FOR_STEREOTACTIC_RADIOSURGERY,,,,,,,,,,
,HAS_PRESENCE_OF_LESIONS_IN_AT_LEAST_X_SITES,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPES_Y_FOR_AT_MOST_Z_WEEKS,,PD_L1_SCORE_TC_OF_AT_LEAST_X,HAS_POTENTIAL_SYMPTOMATIC_HYPERCALCEMIA,HAS_ADEQUATE_VENOUS_ACCESS,,,,,,,,,,
,HAS_SYNCHRONOUS_METASTASTIC_DISEASE,HAS_HAD_CATEGORY_X_TREATMENT_OF_TYPE_Y_AS_MOST_RECENT_LINE,,PD_L1_SCORE_TAP_OF_AT_LEAST_X,HAS_MAGNESIUM_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,MEETS_REQUIREMENTS_DURING_SIX_MINUTE_WALKING_TEST,,,,,,,,,,
,CAN_PROVIDE_FRESH_TISSUE_SAMPLE_FOR_FURTHER_ANALYSIS,HAS_HAD_CATEGORY_X_TREATMENT_WITH_ANY_INTENT_Y,,PD_L1_SCORE_TAP_OF_AT_MOST_X,HAS_CORRECTED_MAGNESIUM_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,CAN_PROVIDE_ARCHIVAL_OR_FRESH_TISSUE_SAMPLE_FOR_FURTHER_ANALYSIS,HAS_HAD_CATEGORY_X_TREATMENT_WITH_ANY_INTENT_Y_WITHIN_Z_MONTHS,,PD_L1_STATUS_MUST_BE_AVAILABLE,HAS_PHOSPHATE_MMOL_PER_L_OF_AT_MOST_X,,,,,,,,,,,
,MEETS_SPECIFIC_REQUIREMENTS _REGARDING_BIOPSY,HAS_HAD_ADJUVANT_CATEGORY_X_TREATMENT,,HAS_PSMA_POSITIVE_PET_SCAN,HAS_PHOSPHATE_ULN_OF_AT_MOST_X,,,,,,,,,,,
,HAS_EVALUABLE_DISEASE,HAS_HAD_ADJUVANT_CATEGORY_X_TREATMENT_WITHIN_Y_WEEKS,,MOLECULAR_RESULTS_MUST_BE_AVAILABLE,HAS_PHOSPHATE_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,HAS_MEASURABLE_DISEASE,HAS_HAD_SYSTEMIC_THERAPY_WITH_ANY_INTENT_X,,MOLECULAR_TEST_RESULT_IS_KNOWN_FOR_GENE_X,HAS_POTASSIUM_MMOL_PER_L_OF_AT_LEAST_X,,,,,,,,,,,
,HAS_MEASURABLE_DISEASE_RECIST,HAS_HAD_SYSTEMIC_THERAPY_WITH_ANY_INTENT_X_WITHIN_Y_WEEKS,,MOLECULAR_TEST_RESULT_IS_KNOWN_FOR_PROMOTER_OF_GENE_X,HAS_POTASSIUM_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,HAS_MEASURABLE_DISEASE_RANO,HAS_HAD_SYSTEMIC_THERAPY_WITH_ANY_INTENT_X_AT_LEAST_Y_WEEKS_AGO,,MMR_STATUS_IS_AVAILABLE,HAS_CORRECTED_POTASSIUM_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,HAS_PROGRESSIVE_DISEASE_ACCORDING_TO_SPECIFIC_CRITERIA,HAS_HAD_SYSTEMIC_TREATMENT_ONLY_OF_CATEGORY_X_AND_TYPE_Y,,HAS_KNOWN_NSCLC_DRIVER_GENE_STATUSES,HAS_POTENTIAL_HYPOKALEMIA,,,,,,,,,,,
,HAS_RAPID_PROGRESSIVE_DISEASE,HAS_HAD_SYSTEMIC_TREATMENT_IN_ADVANCED_OR_METASTATIC_SETTING,,HAS_EGFR_PACC_MUTATION,HAS_POTENTIAL_HYPOMAGNESEMIA,,,,,,,,,,,
,HAS_INJECTION_AMENABLE_LESION,HAS_RECEIVED_PLATINUM_BASED_DOUBLET,,HAS_CODELETION_OF_CHROMOSOME_ARMS_X_AND_Y,HAS_POTENTIAL_HYPOCALCEMIA,,,,,,,,,,,
,HAS_MRI_VOLUME_MEASUREMENT_AMENABLE_LESION,HAS_HAD_OBJECTIVE_CLINICAL_BENEFIT_FOLLOWING_TREATMENT_WITH_ANY_NAME_X,,HAS_PROTEIN_X_POLYMORPHISM_Y,HAS_SERUM_TESTOSTERONE_NG_PER_DL_OF_AT_MOST_X,,,,,,,,,,,
,HAS_EVIDENCE_OF_CNS_HEMORRHAGE_BY_MRI,HAS_HAD_OBJECTIVE_CLINICAL_BENEFIT_FOLLOWING_CATEGORY_X_TREATMENT,,,HAS_CORTISOL_LLN_OF_AT_LEAST_X,,,,,,,,,,,
,HAS_INTRATUMORAL_HEMORRHAGE_BY_MRI,HAS_HAD_OBJECTIVE_CLINICAL_BENEFIT_FOLLOWING_CATEGORY_X_TREATMENT_OF_TYPES_Y,,,HAS_AFP_ULN_OF_AT_LEAST_X,,,,,,,,,,,
,HAS_LOW_RISK_OF_HEMORRHAGE_UPON_TREATMENT,HAS_HAD_ONLY_CATEGORY_X_TREATMENT_OF_TYPES_Y,,,HAS_CA125_ULN_OF_AT_LEAST_X,,,,,,,,,,,
,HAS_SUPERSCAN_BONE_SCAN,HAS_HAD_SOC_TARGETED_THERAPY_FOR_NSCLC,,,HAS_HCG_ULN_OF_AT_LEAST_X,,,,,,,,,,,
,HAS_BCLC_STAGE_X,HAS_HAD_SOC_TARGETED_THERAPY_FOR_NSCLC_EXCLUDING_DRIVER_GENES_X,,,HAS_LDH_ULN_OF_AT_MOST_X,,,,,,,,,,,
,HAS_LEFT_SIDED_COLORECTAL_TUMOR,HAS_HAD_TARGETED_THERAPY_INTERFERING_WITH_RAS_MEK_MAPK_PATHWAY,,,HAS_PSA_UG_PER_L_OF_AT_LEAST_X,,,,,,,,,,,
,HAS_SYMPTOMS_OF_PRIMARY_TUMOR_IN_SITU,HAS_HAD_NON_INTERNAL_RADIOTHERAPY,,,HAS_PSA_LLN_OF_AT_LEAST_X,,,,,,,,,,,
,CANCER_TYPE_X,HAS_HAD_RADIOTHERAPY_TO_BODY_LOCATION_X,,,HAS_TOTAL_PROTEIN_IN_URINE_OF_AT_LEAST_X,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_NAME_X_TREATMENT,,,HAS_TOTAL_PROTEIN_IN_24H_URINE_OF_AT_LEAST_X,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_CATEGORY_X_TREATMENT,,,HAS_ADEQUATE_ORGAN_FUNCTION,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_CATEGORY_X_TREATMENT_OF_TYPES_Y,,,HAS_GLUCOSE_FASTING_PLASMA_MMOL_PER_L_OF_AT_MOST_X,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_CATEGORY_X_TREATMENT_OF_TYPES_Y_AND_AT_LEAST_Z_WEEKS,,,HAS_FREE_THYROXINE_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_CATEGORY_X_TREATMENT_OF_TYPES_Y_AND_AT_LEAST_Z_CYCLES,,,HAS_FREE_TRIIODOTHYRONINE_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_AT_LEAST_X_TREATMENT_LINES,,,HAS_BOUND_TRIIODOTHYRONINE_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_TREATMENT_WITH_ANY_DRUG_X,,,HAS_TSH_WITHIN_INSTITUTIONAL_NORMAL_LIMITS,,,,,,,,,,,
,,HAS_PROGRESSIVE_DISEASE_FOLLOWING_FIRST_LINE_CATEGORY_X_OF_TYPES_Y_TREATMENT,,,HAS_ANTI_HLA_ANTIBODIES_AGAINST_PDC_LINE,,,,,,,,,,,
,,HAS_ACQUIRED_RESISTANCE_TO_DRUG_X,,,HAS_CD4_POSITIVE_CELLS_MILLIONS_PER_LITER_OF_AT_LEAST_X,,,,,,,,,,,
,,HAS_RADIOLOGICAL_PROGRESSIVE_DISEASE_FOLLOWING_AT_LEAST_X_TREATMENT_LINES,,,,,,,,,,,,,,
,,HAS_RADIOLOGICAL_PROGRESSIVE_DISEASE_AFTER_LATEST_TREATMENT_LINE,,,,,,,,,,,,,,
,,HAS_HAD_DEFINITIVE_LOCOREGIONAL_THERAPY_WITH_CURATIVE_INTENT,,,,,,,,,,,,,,
,,HAS_HAD_COMPLETE_RESECTION,,,,,,,,,,,,,,
,,HAS_HAD_PARTIAL_RESECTION,,,,,,,,,,,,,,
,,HAS_HAD_RESECTION_WITHIN_X_WEEKS,,,,,,,,,,,,,,
,,MEETS_SPECIFIC_CRITERIA_FOR_RESECTION,,,,,,,,,,,,,,
,,HAD_HAD_LIVER_RESECTION,,,,,,,,,,,,,,
,,HAS_HAD_LOCAL_HEPATIC_THERAPY_WITHIN_X_WEEKS,,,,,,,,,,,,,,
,,HAS_HAD_INTRATUMORAL_INJECTION_TREATMENT,,,,,,,,,,,,,,
,,HAS_CUMULATIVE_ANTHRACYCLINE_EXPOSURE_OF_AT_MOST_X_MG_PER_M2_DOXORUBICIN_OR_EQUIVALENT,,,,,,,,,,,,,,
,,HAS_PATHOLOGICAL_COMPLETE_RESPONSE_AFTER_SURGERY,,,,,,,,,,,,,,
,,HAS_PREVIOUSLY_PARTICIPATED_IN_TRIAL,,,,,,,,,,,,,,
,,HAS_PREVIOUSLY_PARTICIPATED_IN_TRIAL_X,,,,,,,,,,,,,,
,,IS_NOT_PARTICIPATING_IN_ANOTHER_TRIAL,,,,,,,,,,,,,,
,,HAS_RECEIVED_POTENTIAL_SYSTEMIC_TREATMENT_FOR_BRAIN_METASTASES,,,,,,,,,,,,,,
,,HAS_HAD_BRAIN_RADIATION_THERAPY,,,,,,,,,,,,,,